Telmoliv-AMH
July 1, 2026
Caliq 10
July 1, 2026
Telmoliv-AM
Telmisartan & Amlodipine Tablets
Telmoliv-AM is a bilayered tablet that combines Telmisartan (40mg) and Amlodipine (5mg), two highly effective antihypertensive agents. This dual-action medication helps in controlling high blood pressure (hypertension) and reducing the risk of cardiovascular complications such as heart attacks and strokes.
Telmisartan is an angiotensin II receptor blocker (ARB) that relaxes blood vessels by preventing the effects of angiotensin II, a hormone that causes vasoconstriction and fluid retention.
Amlodipine is a calcium channel blocker (CCB) that dilates blood vessels and improves blood flow by relaxing the smooth muscles of the arterial walls.
By combining these two mechanisms, Telmoliv-AM offers effective and sustained blood pressure control, reducing the strain on the heart and preventing organ damage due to prolonged hypertension.
Key Benefits:
✅ Effectively lowers blood pressure and maintains cardiovascular health.
✅ Prevents heart-related complications such as stroke, heart attack, and kidney damage.
✅ Provides a dual mechanism of action for better hypertension management.
✅ Offers once-daily dosing for patient convenience.
Telmoliv-AM is an essential medication in the management of hypertension and cardiovascular diseases, helping patients maintain a healthy heart and circulatory system.
Possible side effects include dizziness, headache, swelling in the ankles or feet, flushing, fatigue, muscle cramps, and low blood pressure. In rare cases, serious allergic reactions or irregular heartbeat may occur. Seek medical advice if symptoms persist or worsen.
Telmoliv-AM is indicated for the treatment of hypertension (high blood pressure) and to reduce the risk of cardiovascular events, including heart attacks and strokes.
Take Telmoliv-AM exactly as prescribed by your doctor. Avoid abrupt discontinuation, as it may cause a sudden rise in blood pressure. Regular blood pressure monitoring is recommended to assess treatment effectiveness.
Store in a cool, dry place, away from moisture, heat, and direct sunlight. Keep out of reach of children.
Telmoliv-AM is a bilayered tablet that combines Telmisartan (40mg) and Amlodipine (5mg), two highly effective antihypertensive agents. This dual-action medication helps in controlling high blood pressure (hypertension) and reducing the risk of cardiovascular complications such as heart attacks and strokes.
Telmisartan is an angiotensin II receptor blocker (ARB) that relaxes blood vessels by preventing the effects of angiotensin II, a hormone that causes vasoconstriction and fluid retention.
Amlodipine is a calcium channel blocker (CCB) that dilates blood vessels and improves blood flow by relaxing the smooth muscles of the arterial walls.
By combining these two mechanisms, Telmoliv-AM offers effective and sustained blood pressure control, reducing the strain on the heart and preventing organ damage due to prolonged hypertension.
Key Benefits:
✅ Effectively lowers blood pressure and maintains cardiovascular health.
✅ Prevents heart-related complications such as stroke, heart attack, and kidney damage.
✅ Provides a dual mechanism of action for better hypertension management.
✅ Offers once-daily dosing for patient convenience.
Telmoliv-AM is an essential medication in the management of hypertension and cardiovascular diseases, helping patients maintain a healthy heart and circulatory system.
